missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. VLDLR Rabbit anti-Human, Rat, Clone: VLDLR/2896R, Novus Biologicals™

VLDLR Rabbit anti-Human, Rat, Clone: VLDLR/2896R, Novus Biologicals™

Rabbit Monoclonal Antibody

528.00€

Specifications

Antigen VLDLR
Clone VLDLR/2896R
Concentration 0.2 mg/mL
Dilution ELISA
Applications ELISA
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18663117
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP3-07198-100ug 		100 μg
528.00€
100µg
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

VLDLR Monoclonal specifically detects VLDLR in Human, Rat samples. It is validated for ELISA.
Specifications

Specifications

VLDLR
0.2 mg/mL
ELISA
Unconjugated
Rabbit
Apoptosis, Cholesterol Metabolism, Lipid and Metabolism, Neurodegeneration, Neuronal Cell Markers, Neuroscience
10 mM PBS with 0.05% BSA
7436
IgG
Protein A or G purified
VLDLR/2896R
ELISA
Monoclonal
Purified
RUO
Human, Rat
CARMQ1, CHRMQ1, FLJ35024, very low density lipoprotein receptor, very low-density lipoprotein receptor, VLDL receptor, VLDL-R, VLDLRCH
Recombinant human VLDLR fragment from c-terminal
Primary
Store at 4°C.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.